Accurate metabolite characterization
plays a vital role in targeted
metabolomics. Nonetheless, the library of metabolites is still limited,
especially for downstream conjugates, and it is time-consuming to
synthesize each of these compounds due to high structural diversity.
Herein, a green and smart strategy was developed to expand the scope
of targeted metabolomics. The reference standards were synthesized
in a one-pot microscale reaction, and the analytical method was tailored
using the synthetic products. A group of new metabolites, namely bile
acid–amino acid conjugates (BA–AAs), was studied as
a proof-of-concept. First, in total 160 BA–AAs were synthesized
using a small amount (2 mg each) of bile acids and low-toxic reagents
within 4 h. Then, an ultra-high-performance liquid chromatography
/Orbitrap-MS method was established to comprehensively profile 202
bile acid derivatives in 20 min. Finally, the method was applied to
mice with inflammatory bowel disease (IBD) to discover the accumulation
of 70 rare BA–AAs in small intestine and liver, where 55 were
first reported from biosamples. These BA–AAs are farnesoid
X receptor modulators and might contribute to the development of IBD.
Our study demonstrated a feasible approach for the broad-spectrum
targeted metabolomics of bile acids.